Cargando…
Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study
Various types of botulinum toxin (BoNT) have been studied to treat cervical dystonia (CD). Although high-dose BoNT has proven efficacy, it increases the risk of adverse events. For this reason, this study was planned to identify the non-inferiority efficacy, tolerability, and safety of low-dose neub...
Autores principales: | Kongsaengdao, Subsai, Arayawithchanont, Arkhom, Samintharapanya, Kanoksri, Rojanapitayakorn, Pichai, Maneeton, Benchalak, Maneeton, Narong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541224/ https://www.ncbi.nlm.nih.gov/pubmed/34678987 http://dx.doi.org/10.3390/toxins13100694 |
Ejemplares similares
-
Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study
por: Kongsaengdao, Subsai, et al.
Publicado: (2018) -
Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study
por: Kongsaengdao, Subsai, et al.
Publicado: (2017) -
The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A
por: Kongsaengdao, Subsai, et al.
Publicado: (2021) -
Effectiveness of Favipiravir monotherapy in the treatment of COVID-19: real world data analysis from Thailand
por: Srisubat, Attasit, et al.
Publicado: (2023) -
Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Maneeton, Benchalak, et al.
Publicado: (2022)